Is L, Ceoloni B, Barbieri AM, Bordogna P, et al. Pseudohypoparathyroidism

Is L, Ceoloni B, Barbieri AM, 25331948 Bordogna P, et al. Pseudohypoparathyroidism form Ia and pseudo-pseudohypoparathyroidism: the increasing spectrum of GNAS inactivating mutations. Hum Mutat 34: 411416. 34. Fernandez-Rebollo E, Lecumberri B, Gaztambide S, Martinez-Indart L, Perez de Nanclares G, et al. Endocrine profile and phenotype-genotype correlation in Spanish sufferers with pseudohypoparathyroidism. J Clin Endocrinol Metab 98: E9961006. 35. Farfel Z, Bourne HR, Iiri T The expanding spectrum of G protein ailments. N Engl J Med 340: 10121020. 36. Gelfand IM, Eugster EA, DiMeglio LA Presentation and clinical progression of pseudohypoparathyroidism with multi-hormone resistance and Albright hereditary osteodystrophy: a case series. J Pediatr 149: 877880. 37. Adegbite NS, Xu M, Kaplan FS, Shore EM, Pignolo RJ Diagnostic and mutational spectrum of progressive osseous heteroplasia along with other kinds of GNAS-based heterotopic ossification. Am J Med Genet A 146A: 17881796. 38. Bertaux K, Broux O, Chauveau C, Hardouin P, Jeanfils J, et al. Runx2 regulates the expression of GNAS on Epigenetic Reader Domain SaOs-2 cells. Bone 38: 943950. 39. Craigen WJ, Lindsay EA, Bricker JT, Hawkins EP, Baldini A Deletion of chromosome 22q11 and pseudohypoparathyroidism. Am J Med Genet 72: 63 65. 40. Phelan MC, Rogers RC, Clarkson KB, Bowyer FP, Levine MA, et al. Albright hereditary osteodystrophy and del in 4 unrelated people. Am J Med Genet 58: 17. 41. Strachan T, Study AP Human genetic variability and its consequences. In: Strachan T, Study AP, editors. Human Molecular Genetics. 4th ed. New York: Garland Science. Autophagy 405440. 42. Bastepe M, Gunes Y, Perez-Villamil B, Hunzelman J, Weinstein LS, et al. Receptor-mediated adenylyl cyclase activation through XLalpha, the extralarge variant of your stimulatory G protein alpha-subunit. Mol Endocrinol 16: 19121919. 43. Romano M, Marcucci R, Baralle FE Splicing of constitutive upstream introns is crucial for the recognition of intra-exonic suboptimal splice web-sites in the thrombopoietin gene. Nucleic Acids Res 29: 886894. 44. Cooper TA Use of minigene systems to dissect option splicing elements. Strategies 37: 331340. 45. Culbertson MR RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet 15: 7480. 46. D’Souza-Li L, Canaff L, Janicic N, Cole DE, Hendy GN An acceptor splice web-site mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Hum Mutat 18: 411421. 47. Hwang DY, Hung CC, Riepe FG, Auchus RJ, Kulle AE, et al. CYP17A1 intron mutation causing cryptic splicing in 17alpha-hydroxylase deficiency. PLoS One particular 6: e25492. 48. Ishigaki Y, Li X, Serin G, Maquat LE Evidence for any pioneer round of mRNA translation: mRNAs topic to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20. Cell 106: 607617. 49. Harries LW, Hattersley AT, Ellard S Messenger RNA transcripts with the hepatocyte nuclear factor-1alpha gene containing premature termination codons are topic to nonsense-mediated decay. Diabetes 53: 500504. 50. de Sanctis L, Vai S, Andreo MR, Romagnolo D, Silvestro L, et al. Brachydactyly in 14 genetically characterized pseudohypoparathyroidism kind Ia individuals. J Clin Endocrinol Metab 89: 16501655. 51. Bastepe M, Juppner H Editorial: Pseudohypoparathyroidism and mechanisms of resistance toward a number of hormones: molecular evidence to clinical presentation. J Clin Endocrinol Metab 88: 40554058. 52. Mantova.Is L, Ceoloni B, Barbieri AM, 25331948 Bordogna P, et al. Pseudohypoparathyroidism sort Ia and pseudo-pseudohypoparathyroidism: the increasing spectrum of GNAS inactivating mutations. Hum Mutat 34: 411416. 34. Fernandez-Rebollo E, Lecumberri B, Gaztambide S, Martinez-Indart L, Perez de Nanclares G, et al. Endocrine profile and phenotype-genotype correlation in Spanish individuals with pseudohypoparathyroidism. J Clin Endocrinol Metab 98: E9961006. 35. Farfel Z, Bourne HR, Iiri T The expanding spectrum of G protein ailments. N Engl J Med 340: 10121020. 36. Gelfand IM, Eugster EA, DiMeglio LA Presentation and clinical progression of pseudohypoparathyroidism with multi-hormone resistance and Albright hereditary osteodystrophy: a case series. J Pediatr 149: 877880. 37. Adegbite NS, Xu M, Kaplan FS, Shore EM, Pignolo RJ Diagnostic and mutational spectrum of progressive osseous heteroplasia and also other kinds of GNAS-based heterotopic ossification. Am J Med Genet A 146A: 17881796. 38. Bertaux K, Broux O, Chauveau C, Hardouin P, Jeanfils J, et al. Runx2 regulates the expression of GNAS on SaOs-2 cells. Bone 38: 943950. 39. Craigen WJ, Lindsay EA, Bricker JT, Hawkins EP, Baldini A Deletion of chromosome 22q11 and pseudohypoparathyroidism. Am J Med Genet 72: 63 65. 40. Phelan MC, Rogers RC, Clarkson KB, Bowyer FP, Levine MA, et al. Albright hereditary osteodystrophy and del in four unrelated people. Am J Med Genet 58: 17. 41. Strachan T, Read AP Human genetic variability and its consequences. In: Strachan T, Study AP, editors. Human Molecular Genetics. 4th ed. New York: Garland Science. 405440. 42. Bastepe M, Gunes Y, Perez-Villamil B, Hunzelman J, Weinstein LS, et al. Receptor-mediated adenylyl cyclase activation by way of XLalpha, the extralarge variant of the stimulatory G protein alpha-subunit. Mol Endocrinol 16: 19121919. 43. Romano M, Marcucci R, Baralle FE Splicing of constitutive upstream introns is crucial for the recognition of intra-exonic suboptimal splice sites inside the thrombopoietin gene. Nucleic Acids Res 29: 886894. 44. Cooper TA Use of minigene systems to dissect alternative splicing components. Procedures 37: 331340. 45. Culbertson MR RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet 15: 7480. 46. D’Souza-Li L, Canaff L, Janicic N, Cole DE, Hendy GN An acceptor splice website mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal extreme hyperparathyroidism. Hum Mutat 18: 411421. 47. Hwang DY, Hung CC, Riepe FG, Auchus RJ, Kulle AE, et al. CYP17A1 intron mutation causing cryptic splicing in 17alpha-hydroxylase deficiency. PLoS A single six: e25492. 48. Ishigaki Y, Li X, Serin G, Maquat LE Proof for any pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20. Cell 106: 607617. 49. Harries LW, Hattersley AT, Ellard S Messenger RNA transcripts from the hepatocyte nuclear factor-1alpha gene containing premature termination codons are subject to nonsense-mediated decay. Diabetes 53: 500504. 50. de Sanctis L, Vai S, Andreo MR, Romagnolo D, Silvestro L, et al. Brachydactyly in 14 genetically characterized pseudohypoparathyroidism form Ia individuals. J Clin Endocrinol Metab 89: 16501655. 51. Bastepe M, Juppner H Editorial: Pseudohypoparathyroidism and mechanisms of resistance toward numerous hormones: molecular proof to clinical presentation. J Clin Endocrinol Metab 88: 40554058. 52. Mantova.

Leave a Reply